Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Medical device makers should address cybersecurity safeguards throughout the life of their products, according to recent draft guidance from the FDA. The proposed recommendations apply to devices that contain software or programmable logic, but not to investigational or experimental devices (http://1.usa.gov/1Q3wxyr).
The agency noted that manufacturers should address the potential for cyber threats during initial product design and development. However, postmarketing cybersecurity risk management programs are essential, the FDA stressed.
Voelker R. Making Devices Cyber Safe. JAMA. 2016;315(9):861. doi:10.1001/jama.2016.1283
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: